Starting from November 30, 2024, ordinary passport holders from 38 countries can be exempted from visa to enter China and stay for no more than 30 days for business, tourism, family visit, exchange and transit purposes. 

Database building is a link to high-throughput sequencing.

Recently, leading molecular diagnostic data analysis startup Tempus announced the completion of E round of financing, with a total financing of 110 million dollars. This is Tempus third financing in 11 months. After this round of financing,

Premaitha Health said recentlythat it has settled its patent dispute and signed a licensing and supply agreement with Illumina related to noninvasive prenatal testing technology. Under the agreement, Manchester, UK-based Premaitha has licens

Quadrant Biosciences said recentlythat it hasreceived a $2 million grant from the National Institutes of Health to finalize development of a saliva-based diagnostic for autism spectrum disorder(ASD). According to Syracuse, New York-based Qua

Agendia recentlyannounced a partnership with GeneCast Biotechnology to make its breast cancer tests available in China. Under the terms of the deal, Beijing-based GeneCast has the exclusive right to market Agendias MammaPrint and BluePrint t

Early treatment ofautism spectrum disorder(ASD) can significantly improve the lives of affected children and their families, but diagnosing the disorder is often a challenge. A company in Syracuse, NY hasdeveloped an epigenetic test that cou

Researchers from Aromyx Corp. announced this month that the companys flagship technology, the EssenceChip, will be made available to select partners by the end of this year. The new biosensor technology was designed to work with a digital pl

doesnt shy away from speaking about biocompatibility topics related to medical devices. Turley serves as a senior biocompatibility expert for Nelson Labs. The Salt Lake City, UT-based lab serves as an independent consultant that can help nav

An Epic Approach Toward Liquid Biopsy 液体活检 史诗般的方法 The liquid biopsy space continues to attract investors and bring in financings that are typically above the average amount medtech firms are able to raise. Epic Sciences

Medical device designers have a new research tool in their arsenal that facilitates faster immersion for the development team and provides a communication platform to bring patients and healthcare professionals into the development process.

Biodesix Makes the Case for VeriStrat Through New Study Biodesix通过新的研究证明了VeriStrat的可行性 The Biodesix VeriStrat test received an extra dose of validation last week through a 1,048-patient study published in the Oncol